|
ANTX
|
AN2 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AVTR
|
Avantor, Inc.
|
US
|
NYSE
|
|
BDX
|
Becton, Dickinson and Company
|
US
|
NYSE
|
|
BRKR
|
Bruker Corporation
|
US
|
NASDAQ
|
|
CFRX
|
ContraFect Corporation
|
US
|
NASDAQ
|
|
COCP
|
Cocrystal Pharma, Inc.
|
US
|
NASDAQ
|
|
GNCA
|
Genocea Biosciences, Inc.
|
US
|
NASDAQ
|
|
IBIO
|
iBio, Inc.
|
US
|
AMEX
|
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
|
IMRN
|
Immuron Limited
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
US
|
NASDAQ
|
|
KLDO
|
Kaleido Biosciences, Inc.
|
US
|
NASDAQ
|
|
STE
|
STERIS Corporation
|
US
|
NYSE
|
|
BIT
|
Biotron Limited
|
AU
|
ASX
|
|
BXN
|
Bioxyne Ltd
|
AU
|
ASX
|
|
LBT
|
LBT Innovations Limited
|
AU
|
ASX
|
|
MAP
|
Microba Life Sciences Ltd
|
AU
|
ASX
|
|
NXS
|
Next Science Limited
|
AU
|
ASX
|
|
CSUI
|
Cannabis Suisse Corp
|
US
|
OTC
|
|
HXBM
|
Helix Biomedix Inc
|
US
|
OTC
|